InfraStrata CEO John Wood delivers robust operational update Watch Now

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price: 1,665.00
Bid: 1,663.60
Ask: 1,664.20
Change: 26.40 (1.61%)
Spread: 0.60 (0.04%)
Open: 1,646.60
High: 1,672.00
Low: 1,645.40
Yest. Close: 1,638.60
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
15th Jul 20196:19 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
15th Jul 20196:18 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
15th Jul 20196:16 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
15th Jul 201911:42 amRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
15th Jul 20197:00 amRNSGlaxoSmithKline PLC - positive results in Phase 3 PRIMA study of ZEJULA
12th Jul 20194:35 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
12th Jul 20193:55 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
10th Jul 20193:48 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
10th Jul 20197:00 amRNSGlaxoSmithKline PLC - ViiV switch study shows 2DR as effective as 3DR
3rd Jul 20199:00 amRNSGlaxoSmithKline PLC - ViiV receives Dovato EU Marketing Authorisation
1st Jul 201912:08 pmRNSGlaxoSmithKline PLC - Total Voting Rights
12th Jun 20195:10 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
7th Jun 20197:00 amRNSGlaxoSmithKline PLC - FDA approval for Nucala self-administration
4th Jun 20198:00 amRNSGlaxoSmithKline PLC - CHMP positive on GSK's Nucala self-administration
3rd Jun 20192:31 pmRNSGlaxoSmithKline PLC - Total Voting Rights
24th May 201910:54 amRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
20th May 20191:44 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
13th May 20195:44 pmRNSGlaxoSmithKline PLC - Block listing Interim Review
13th May 20194:19 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
8th May 20196:23 pmRNSGlaxoSmithKline PLC - Result of AGM & GM
2nd May 20195:07 pmRNSGlaxoSmithKline PLC - Trelegy Ellipta asthma study met primary endpoint
1st May 20193:11 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
1st May 20192:32 pmRNSGlaxoSmithKline PLC - Total Voting Rights
1st May 201912:00 pmRNSGlaxoSmithKline PLC - 1st Quarter Results
29th Apr 201912:00 pmRNSGlaxoSmithKline PLC - ViiV submits NDA for HIV monthly 2 drug injectable
26th Apr 20194:16 pmRNSGlaxoSmithKline PLC - ViiV receives CHMP Positive Opinion for Dovato
16th Apr 20195:36 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
16th Apr 20195:35 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
16th Apr 20195:23 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
16th Apr 20195:14 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
15th Apr 20192:45 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
12th Apr 20194:47 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
12th Apr 20194:33 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
11th Apr 20195:01 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
9th Apr 20197:00 amRNSGlaxoSmithKline PLC - FDA approves ViiV's two-drug HIV regimen, Dovato
2nd Apr 20191:00 pmRNSGlaxoSmithKline PLC - Publication of AGM and GM Shareholder Documents
1st Apr 20194:36 pmRNSGlaxoSmithKline PLC - Total Voting Rights
28th Mar 20194:15 pmRNSGlaxoSmithKline PLC - GSK reporting changes - product sales and IFRS 16
25th Mar 20195:02 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
21st Mar 20194:00 pmRNSGlaxoSmithKline PLC - GSK announces further positive data from DREAMM-1
19th Mar 20195:45 pmRNSGlaxoSmithKline PLC - Data from GARNET study evaluating dostarlimab
18th Mar 20197:00 amRNSGlaxoSmithKline PLC - GSK Annual Report 2018 on Form 20-F
12th Mar 20193:19 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
12th Mar 20191:00 pmRNSGlaxoSmithKline PLC - Annual Financial Report
11th Mar 20196:24 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
8th Mar 20197:00 amRNSGlaxoSmithKline PLC - ViiV positive ph3 data for long acting injectable
5th Mar 20195:20 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
1st Mar 201910:10 amRNSGlaxoSmithKline PLC - Total Voting Rights
22nd Feb 20195:30 pmRNSGlaxoSmithKline PLC - Director/PDMR Shareholding
22nd Feb 201911:21 amRNSGlaxoSmithKline PLC - GSK response to SFO Statement

Login to your account

Don't have an account? Click here to register.